Taking Omega-3 and Still Have Dry Eyes? Your Genes May Be Why.

MTHFR is an enzyme that converts folate into its active form, methylfolate. This is the first step in a process called methylation, which your cells use for hundreds of tasks, including making neurotransmitters, detoxifying chemicals, and regulating inflammation. If methylation is running smoothly, your body can process nutrients efficiently and keep inflammatory signals under control.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme activity by 40 to 70%. This means your cells are struggling to convert the folate in your diet and supplements into the forms they actually need. The downstream effect is elevated homocysteine, which is toxic to blood vessels and impairs nitric oxide synthesis, a molecule critical for vascular function.

For your eyes specifically, this matters because the lacrimal glands (which produce tears) require constant microcirculation to function. Impaired blood flow from reduced nitric oxide production means less nutrient and oxygen delivery to the cells that make tears. You can take all the omega-3 you want, but if methylation is blocked, your body struggles to process it into EPA and DHA, the specific forms that reduce eye inflammation.

COMT is an enzyme that breaks down dopamine, norepinephrine, and estrogen. It also modulates nitric oxide production. People with slow COMT variants clear these neurotransmitters more slowly, meaning they accumulate to higher levels. People with fast variants clear them quickly, meaning they run lower.

The Val158Met variant is the most common, with roughly 25% of people being homozygous slow in European ancestry. Slow COMT variants tend toward higher dopamine and norepinephrine, which drives a more reactive stress response and elevates cortisol. This chronic stress activation triggers sustained inflammation throughout the body, including in the meibomian glands and lacrimal glands that produce tears.

Your eyes experience this as a vicious cycle: elevated cortisol pushes your immune system toward Th1 and Th17 responses, which attack the oil-producing glands in your eyelids. Inflammation increases, tear production drops, and the tear film destabilizes. You’re essentially running a low-grade inflammatory fire in the tissues that should be protecting your eyes.

TNF-alpha is a master inflammatory molecule. It signals immune cells to migrate to inflamed tissue, amplifies inflammatory cascades, and drives the production of other pro-inflammatory cytokines. In measured amounts, TNF-alpha is protective. In excess, it becomes destructive.

The -308G>A variant, present in roughly 30% of people with European ancestry, increases TNF-alpha production. People with this variant tend to mount a stronger inflammatory response to any trigger, from a minor infection to an allergen to simple stress. This hyperactive TNF response can target the lacrimal and meibomian glands, treating them as threats and attacking the cells responsible for tear production and tear-film composition.

For your dry eyes, elevated TNF-alpha means chronic low-grade immune attack on the tissues that produce tears. You feel this as persistent grittiness, burning, and a sensation that your eyes are constantly irritated. Omega-3s help, but they’re trying to calm a fire that’s being constantly stoked by genetic predisposition.

Interleukin-6 is often called the secondary inflammatory cytokine because TNF-alpha and IL-1B trigger its release. Once released, IL-6 amplifies the inflammatory signal, recruits more immune cells, and drives the production of downstream inflammatory molecules. It is particularly involved in systemic inflammation and neuroinflammation.

The -174G>C variant, carried by roughly 40% of people, shifts the immune system toward higher IL-6 production. This means that once an inflammatory cascade starts, your body amplifies it more aggressively than someone without this variant. If TNF-alpha triggers inflammation in your meibomian glands, IL-6 makes that inflammation spread and persist longer.

In your eyes, this creates a situation where minor irritants or allergens trigger an oversized inflammatory response that takes days or weeks to resolve. Your tears become inflamed, their protective proteins are degraded more quickly, and the tear film destabilizes faster than it can regenerate.

SOD2 is superoxide dismutase 2, an enzyme that sits inside mitochondria and neutralizes reactive oxygen species (ROS), the toxic byproducts of energy production. When SOD2 is working well, your cells generate energy without accumulating oxidative damage. When SOD2 function is impaired, ROS accumulates, damages proteins and lipids, and triggers inflammatory signaling.

The Val16Ala variant, present in roughly 40% of people, reduces SOD2 enzyme activity. This means your cells are generating more oxidative stress than they can neutralize, and that accumulated ROS is driving chronic, low-grade inflammation throughout your tissues. Photoreceptors and lacrimal gland cells are particularly vulnerable because they are metabolically active and produce a lot of ROS as a byproduct.

Your dry eyes feel worse because the proteins that make up your tear film are being oxidatively damaged faster than your body can repair or replace them. The lipid layer of tears is particularly vulnerable to oxidation, making tears break down faster and leaving your cornea exposed.

VDR is the vitamin D receptor, a protein that allows your cells to respond to vitamin D. Vitamin D is far more than a bone mineral; it is a master immune regulator. It dampens Th1 and Th17 inflammatory responses, promotes regulatory T cells, and modulates TNF-alpha and IL-6 production. Without adequate VDR function, your immune system cannot receive vitamin D’s calming signals.

Common VDR variants (FokI, BsmI, ApaI, TaqI) reduce the receptor’s ability to bind and respond to vitamin D. People with less-efficient VDR variants need higher circulating vitamin D levels to achieve the same immune-regulatory effect as people with optimal variants. This is particularly important because vitamin D deficiency or insufficiency is directly associated with autoimmune dry eye and meibomian gland dysfunction.

For your eyes, suboptimal VDR function means your immune system cannot fully respond to vitamin D, leaving inflammatory signals unchecked. The lacrimal and meibomian glands become targets for immune attack. You end up needing higher vitamin D levels and more aggressive immune-supporting protocols than standard recommendations suggest.